In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative.
In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative. In addition to examining the drivers of healthcare spending, the initiative is creating a national multistakeholder dialogue to determine best practices for optimizing spending.
Today, we speak with Bobby Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council, about the initiative, its goals, and what it has found so far.
To listen to the podcast, please login.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or or through one of these podcast services:
Learn more about drug prices in the United States and efforts to lower them:
From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs
Healthcare Spending Driven by Price, Not Utilization: JAMA Study
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More